Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Contribution of Genetics, Non-invasive Neurophysiological Methods, Neuroimaging and Neuropsychology in Identifying the Cause and the Epileptogenic Zone in Focal Cryptogenic Epilepsies

NCT05015868 is registered in ClinicalTrials.gov with IRCCS Eugenio Medea as lead sponsor.

NCT NCT05015868
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05015868 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Contribution of Genetics, Non-invasive Neurophysiological Methods, Neuroimaging and Neuropsychology in Identifying the Cause and the Epileptogenic Zone in Focal Cryptogenic Epilepsies
Lead sponsor
IRCCS Eugenio Medea
Phase
Not applicable
Overall status
Completed
Start date
July 15, 2021
Completion date
December 31, 2024
Enrollment
5 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

epilepsies, partial, epilepsy intractable